Combs Andrew (CIK 1825005) reported 1 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-03-27). Recent activity: Buy PRLD (100,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-03-27 | Prelude Therapeutics Inc (PRLD) | Chief Chemistry Officer | Buy | 100,000 | $69,000 |
Source: SEC Form 4 filings · as of 2025-03-27